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Chapter I
INTRODUCTION
The Shope rabbit fibroma was discovered in 1932 by
Richard E* Shope of the Rockefeller Institute in Princeton,
New Jersey, when he observed small fibromatous tumors
under the skin of a wild cottontail rabbit which he shoto
The tumor was transmissible by means of tissue filtrates
to wild cottontail and domestic rabbits®

The tissue fil

trates given to domestic rabbits produced fibromatous
tumors similar to those found naturally (usually on the
feet) in wild cottontail rabbits.

When transmitted by

inoculation to either the domestic or the cottontail rabbit,
the tumors grew initially quite rapidly but became
stationary and regressed in about 9-12 days, leaving the
rabbit immune to subsequent infection (Allison, 1966).
The Natural Reservoirs of Shope Rabbit Fibroma
The natural reservoirs of Shope rabbit fibroma appear
to be the wild cottontail rabbit.

Kilham and Woke (1953)

demonstrated that fleas and Aedes aegypti mosquitoes fed
on fibromatous tumors on wild cottontail rabbits trans
mitted typical fibromas, usually on the feet and legs, to
healthy cottontail rabbits.

These insects retained the

ability to transmit the tumor for at least 2 weeks after
feeding on a tumor.

In 1955 Kilham and Dalmat found that

three other species of mosquitoes. Anopheles quadrimaculatus.
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Culex pipens, and Aedes triseriatus, were as effective in
transmitting the Shope rabbit fibroma virus as Aedes
aegypti.

They also found that the infected mosquitos

carried the virus, which was localized in the head parts,
for as long as several weeks.

The Shope rabbit fibroma,

though it can be easily transmitted by culture filtrates
and insect bites, is not contagious.
Relationship of Fibroma and Myxoma Virus
Fibroma and myxoma viruses appear to be very closely
related, although the diseases they produce are quite dif
ferent.

Fibroma virus, normally not fatal, produces a local,

benign, fibromatous tumor which usually regresses in domes
tic and cottontail rabbits, and is not transmitted by direct
contact.

Myxoma virus induces an acute, generalized disease

transmissible by direct contact.

The disease is fatal only

for domestic rabbits, whereas cottontail rabbits develop only
a transient localized infection evidenced by a fibromatous
tumor at the site of inoculation.

This lesion is similar

to that induced by fibroma virus in cottontail rabbits.
The similarity in these lesions led Shope (1932) to postu
late an immunological relationship between the two viruses.
He found that recovery from an infection with fibroma virus
decreased susceptibility to a subsequent infection with
myxoma virus.
After recovery from infection with fibroma virus,
domestic rabbits inoculated with myxoma virus developed a
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local myxoma which showed little tendency to generalize.
Most of the animals recovered, suggesting that fibroma
infection provided some degree of protection against
myxoma virus.

Cross-immunity was very difficult to demon

strate in the opposite direction as almost all domestic
animals with primary myxomatosis died.

The very rare rab

bit surviving primary myxomatosis proved to be immune to
subsequent inoculations with either myxoma or fibroma
virus.
From these studies it is evident that animals infected
with fibroma or myxoma virus develop cross-immunity and
that the viruses are closely related

(Shope, 1936).

The

closeness of this relationship was demonstrated in 1939 by
Berry and Dedrick, who accomplished the transformation of
fibroma virus into nqrxoma virus.

Myxoma virus was heat-

inactivated at either 60°C or 73^C and mixed with live
fibroma virus.

This preparation, when injected into the

testicles of normal domestic rabbits, frequently produced
generalized myxomatosis leading to death of the animal.
A control of heated myxoma alone did not produce disease.
These findings were later confirmed by Hust
(1950) and Smith

(1937), Shope

(1952).

Kilham (1957 and 195^) found that the fibroma—myxoma
transformation could be accomplished in tissue culture by
adding heat-inactivated myxoma virus (67°C for 40 minutes)
to live fibroma virus growing in either rabbit kidney cells
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or rabbit testis cells.

The mechanisms of this

transformation are not known, but an exchange of genetic
information must be supposed.
Physical and Chemical Characteristics
Myxoma and fibroma viruses have many characteristics
in common, neither agglutinate red blood cells (Fenner,
1953)» and both are sensitive to ethyl ether and produce
acidophilic intracytoplasmic inclusion bodies in the epi
thelial cells of infected skin lesions and in the ectodermal
cells of the chorioallantoic membrane of chicken embryos.
The diameter of the virus particles is approximately 175 nm
(Schlesinger and Andrews, 1937) by filtration and centri
fugation techniques, while electron microscopy gives a
diameter of about 230-2Ô0 nm.

The viruses are closely

related to vaccinia, fowlpox and ectromelia (Fenner, 1953»
Gaylord and Melnick, 1953) except that the latter three are
not susceptible to ethyl ether.

Cross-immunization and gel

diffusion tests indicate that rabbit fibroma virus is more
closely related to myxoma than to squirrel fibroma virus
(Woodroffe and Fenner, 1965)*

Electron micrographs have

shown that fibroma and myxoma viruses have typical pox
virus morphology (Farrant and Fenner, 1958» Gaylord and
Melnick, 1953» Morgan,

, 1954; Dernhard, 1958) and

are similar in structure (Barnhard, et ^ . , 1954; Lloyd and
Kahler, 1955» Scherrer, I960).

Barnhard, et al. (1954)
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examined ultra-thin sections of fibroma lesions and found
the virus to be an ovoid particle, approximately 230 nm in
diameter.

Outside of the infected cell the virus may have

a brick-shaped structure (Scherre, I960).

The virus

particles are usually found in the cytoplasm of the infected
cell, often aggregate near the cell nucleus, and are visible
as Feulgen-positive inclusion bodies by light microscopy
(Constantin and Febvre, 1956 and 1956).
Tissue Cultures

Faulkner and Andrews (1935) and later Kilham (1956)
propogated fibroma virus in tissue culture of rabbit testis.
This cultured virus was fully infective to rabbits.

The

titer of virus increased after each passage and a maximum
titer of 10”^ was reached in about two weeks after which a
gradual decline began concomitantly with a decrease in via
bility of the tissue culture cells.
attributable to virus proliferation,

No cell death was
Constantin and Bauer

(1956) reported similar results.
Growth of the virus in tissue culture cells was
accompanied by the formation of acidophilic intracytoplasmic
inclusion bodies (Kilham, 1956; Constantin and Febvre, 1956,

1956; Constantin, e^ al. 1956) similar to those noted by
Shope (1932) in fibromas from wild cottontail rabbits.
The virus caused cell destruction in primary kidney
and skin cultures from newborn rabbits (Verna and Eylar,
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1962) and in cell monolayers, produced plaques measuring
from 1 to 2 mm in diameter within four to five days.
Immune serum accentuated the production of these plaques
(Moore and Walker, 1962).

The virus titers determined by

the plaque technique were similar to those obtained by
the titration in the skins of rabbits.

Hinze and Walker

(1964) successfully propagated fibroma virus, not only in
primary kidney cell cultures, but also in serially—cultured
rabbit kidney cells.

After infection these cells lost

contact inhibition and numerous intracytoplasmic inclusion
bodies were observed.

The transformed cells were able to

induce formation of tumors when inoculated into the cheek
pouch of the hamster.
Induction of Generalized Fibromatosis in Rabbits
Although fibroma virus usually produces a mild, benign
and localized lesion in rabbits, under some circumstances
generalized and fatal fibromatosis can be produced.

Andrews

and Ahlstrom (193^) observed that the regression of viral
lesions normally seen was modified by an intramuscular
injection of tar.

Some of the subcutaneous tumors grew

progressively and produced métastasés.

Generalized fibro

matosis, sometimes fatal, resulted after intravenous (i.v.)
injection of virus into tarred animals.

A single dose of

the tar, or of benzpyrine and other carcinogens, on the
day of virus inoculation was sufficient to produce these
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results.

A fibrosarcoma, isolated from a rabbit which had

received 2 intramuscular injections of tar 4 months apart
followed by an i.v. injection of fibroma virus, was trans
planted through a series of 12 rabbit passages.

The first

of these transplanted tumors regressed, but many of the
tumors of later passages grew progressively and some métas
tasés occurred.
the tumor.

Virus particles could not be isolated from

By giving 300-700 R of total body irradiation 24-

hours prior to i.v. injection of fibroma virus, generalized
fibromatosis could also be induced (Clemmesen, 1939)»
Treating rabbits with cortisone after inoculation with
fibroma virus also retards the regression of the tumors
and sometimes results in generalized fibromatosis (Harel
and Constantin, 1954; Allison and Friedman, 1966).

Treat

ment of infected animals with methotrexate retards tumor
regression and may lead to métastasés (Allison and Friedman,

1966).
Fibromatosis in Newborn Rabbits
Inoculation of fibroma virus into newborn rabbits
produces either a generalized, fatal disease or a general
ized or local nonfatal fibrosarcoma.
metastasizing sarcoma can be induced.

Occasionally, a
The age of the rabbit

and the dose of inoculum are the deciding factors for the
type of disease produced (Duran-Reynals , 1940, 1945;

Allison, 1966).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

8
Immunological Aspects
Duran-Reynals (1940, 1945) found that after injection
of virus into adult domestic rabbits, virus was present in
the viscera during the first 8 days of infection, but
viremia did not develop.

Immunity to reinfection was

demonstrable 24 hours after infection and the antibody
response was prompt and vigorous.

However, following simi

lar injections into newborn animals, virus could be detect
ed in the blood for at least 13 days and in the viscera for
at least 21 days.

Immunity to reinfection was not well

established 12 days after infection, the antibody response
developed slowly, and the titers were low.

When large

amounts of virus were injected into newborn rabbits, an
acute lethal disease with destructive, inflammatory, and
proliferative features resulted.

This disease closely

resembled fatal myxomatosis of adult domestic rabbits.

If

small amounts of virus were injected into newborn rabbits,
a progressively-growing tumor and métastasés resulted,
occasionally followed by fatal generalized fibromas.

In

some cases, the tumor regressed after reaching a large size.
These generalized lesions were similar to the generalized
fibromas obtained in rabbits prepared by carcinogens,
immunosuppressants, or whole body irradiation followed by
intravenous injection of fibroma virus.

Allison (1966) and Allison and Friedman (1966), in a
series of experiments with adult and newborn domestic
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rabbits, concluded that recovery from initial infections and
immunity to subsequent infections with rabbit fibroma virus
was due to a cell-mediated immune response*

Adult animals

inoculated with Shope rabbit fibroma developed tumors which
began to regress on about the 9th day*

Delayed-type hyper

sensitivity reactions could be demonstrated by intradermal
injection with virus antigen on the 5th day, and circulat
ing antibody could be demonstrated on the 7th day.

Rabbits

inoculated with virus shortly after birth developed tumors
which grew progressively.

Circulating antibody could be

demonstrated in the newborns on the 7th or 6th day, but no
delayed-type reaction could be elicited even by the passive
transfer of lymph node cells into the skin of adult rabbits
bearing fibromas *
In adult domestic rabbits treated with methotrexate,
an inhibitor of delayed-type hypersensitivity and antibody
formation, regression of fibroma was retarded to the extent
that the tumors became larger than those in control rabbits.
Secondary fibromas developed at sites distant from the orig
inal inoculation site.

Secondary injections of fibroma

virus into rabbits infected with fibroma virus and treated
with methotrexate on the 5th and 7th days induced fibromas
at these sites, while untreated, infected animals were re
sistant to reinfection.

Hyperimmune antifibroma serum

administered to the methotrexate—treated rabbits prevented
the formation of secondary fibromas but did not produce
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necrosis or regression of the fibromas.

In animals

treated with cortisone, delayed hypersensitivity was
suppressed, but some antibody was formed.

Regression of

fibromas in these animals was retarded, and no secondary
lesions developed.

From these results it was postulated

that regression of the fibromas is not due to interferon
or any other factor inherent in the fibroma cells but to
a cell-mediated immune response.

Humoral antibody was

thought to prevent the formation of secondary fibromas but
not to be important in the regression of the primary tumor.

Tompkins, et aJ.. (1969) developed an in vitro measure
of cellular immunity to the fibroma virus ; a modification
of the macrophage inhibition test employing infected mono
layers of PRK cells as the source of antigen.

The capacity

of these monolayers of infected cell homogenates to inhibit
migration of peritoneal exudate cells from fibroma-infected
rabbits paralleled the onset of a cutaneous delayed hyper
sensitivity response and resistance to reinfection in the
intact animal.

Studies using antigens prepared at differ

ent intervals after infection of cells with the virus
suggested that the test is a measure of specific antigen(s)
associated with the cell surface rather than those compon
ents of the intact viron.

Immune serum did not prevent the

antigen from inhibiting migration of sensitized cells but
enhanced inhibition.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

11
Tompkins, et

(1971) characterized the surface

antigen on cells infected by fibroma virus which developed
a surface antigen detectable by immunofluorescence•

Sera

from rabbits with regressed fibroma—induced tumors reacted
with the surface of viable fibroma-infected cells, but not
with cells infected with vaccinia virus, herpesvirus.

Serum

prepared against vaccinia virus, herpesvirus SV40, and
rabbit papilloma virus did not react with fibroma—infected
cells.

The surface antigen seems to develop late and to

depend upon DNA synthesis.

The antibody did not react with

intact virons attached to the cell surface.

The antigen

persisted in associated with the cell membrane long after
infectious virus had decreased to low levels.

A temporal

relationship between the surface antigen measured by the
innumo-fluorescent technique and the antigen measured by
the macrophage inhibition test could be demonstrated.

Anti

body reactive against the surface antigen developed in rab
bits with growing fibromas, and the antibody titer increased
as the tumor regressed.
Statement of Problem

Based upon previous work by Allison (1966) and Allison
and Friedman (1966) this study was proposed to further
elucidate the immune mechanisms involved in recovery from
Shope rabbit fibroma.

Humoral and cell-mediated aspects

of the problem were investigated as well as specific and
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non-specific components of the immune response*
and neonatal rabbits were employed*
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Chapter II
MATERIALS AND METHODS
Animals

Adult New Zealand rabbits of both sexes, weighing
5-7 kg, obtained from local breeders were used throughout
the investigation.

Newborn rabbits of mixed breed from

a breeding colony maintained by the author were also
employed.

All newborn animals were injected with virus at

36 hours of age and weaned at 6 weeks.
were given food and water ^

The adult animals

libitun.

Virus Strain
The Patuxent strain of the Shope rabbit fibroma was
obtained from the American Type Culture Collection (ATCC
Lot No. 2).

The strain, of an unknown passage in rabbits,

was donated by Dr. Lawrence Kilham.

The virus was propa

gated in rabbit testes which were harvested, ground, and
resuspended in Minimum Essential Medium (MEM), Grand Island
Biological Supply Co., Oakland, California.

The cultured

virus was placed in 1 ml volumes in sealed ampules and
stored at -70°C.

This stock virus induced tumors when .2

ml of a 10“^ dilution was given to rabbits.

All animals

were injected intradermally with .2 ml of a 10“’^ dilution
of the original virus suspension.
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BCG Strain
The Paris strain of Mycobacterium bovis, BacilleCalraette-Guerin (BCG) maintained on Dubos medium, Difco,
Detroit, Michigan, was employed for vaccination of the
animals.

A .2 ml volume of a suspension containing 2.4

X 10^ organisms per ml, adjusted to the concentration by
use of a Klett—Summerson Photoelectric colorimeter. New
York, was used.

The organisms were injected intravenously

(i.v.).
Skin-Test Antigens
Two-tenths ml of PPD (NIH, Bethesda, Maryland)

containing 8 ug was used for skin tests.
—1

sensitivity to the virus .2 ml of a 10

To test for skin
—?

and 10”

dilution

of the stock virus suspension heated at 56°C for 30 minutes
was used.
Preparation of Immune Serum, Buffy Coat, Peritoneal
Exudate Cells (PEC) and Spleen Cells
The flanks of rabbits were shaven and 10 intradermal
(i.d.) injections of virus suspension were given.

When

tumor began to regress, the animals received 30 ml of
sterile mineral oil intraperitoneally (i.p.).

Seventy-two

hours later they were bled by cardiac puncture and sacri
ficed.

Blood from half of the animals was drawn in versine-

coated syringes (to prevent clotting) and 10 ml amounts were
administered i.v. to experimental animals.

Blood of the
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remaining animals was allowed to clot, centrifuged, and
the serum was removed.
10 ml doses.

The serum was also given i.v. in

The clots were gently teased through a #60

stainless steel mesh into saline, centrifuged, and the
peripheral white blood cells (buffy coat) were removed.
Cells were counted in a hemocytometer and adjusted to a
concentration of 1 x 10' cells per ml.

Experimental ani

mals received i.v. 2 ml of this suspension.

To collect

the peritoneal cells, sterile MEM was injected into the
peritoneal cavity and then withdrawn together with the oil
and placed in a cold separatory funnel.

The aqueous layer

containing the cells was withdrawn and the cells were washed
twice in MEM, counted in a hemocytometer and adjusted to a
7
final concentration of 1 x 10 cells per ml. Two ml of this
suspension were given i.v. into each experimental animal.
The spleens from immune rabbits were teased through a stain
less steel screen, washed 7 times in MEM, the cells were
counted in a hemocytometer and adjusted to a concentration
7

of 1 X 10' cells per ml.

Two ml of the spleen suspension

were given i.v. to each experimental animal.
Measurement of Tumors and Delayed Reactions
Two diameters of the lesions were measured at right
angles to one another and the approximate area was calcu
lated by multiplying the two values.

Thickness of the

lesion was measured using a ”Schnelltester” system kroplin.
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Volximes of tumors were calculated by multiplying area by
thickness.

Delayed skin reactions were measured in the

same manner and the volumes were calculated by using the
formula suggested by Waksman, 195Ô:
V = (W X L X iT)0.75
measured at right
angles to one
another

^
W = width of lesion in mm
i, - length of lesion in ram
T = thickness of lesion in mm

Anti-Lymphocyte Serum (ALS)
Horse anti— (rabbit lymphocyte) serum (Microbiological)
Associates Lot NO. 10972) was used as an immunological
depressant in newborn animals.

This serum was used either

unabsorbed or absorbed with normal rabbit red blood cells.
Virus Neutralization Test
Two-fold dilutions of the immune serum to be tested
were made in sterile phosphate-buffered saline.

To each of

the dilutions of serum (.2 ml), .2 ml of virus suspension
was added to give a final dilution of 10"^ of virus.

The

mixtures were incubated for 30 minutes at 37^C, and then
injected (.2 ml) into the skin of normal rabbits.
development of lesions was observed for 10 days.

The
The

neutralization titer of the serum was taken as the highest
dilution inhibiting tumor development.
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Isolation of Immunoglobulin
The method used was that of Stelos as detailed in
Weir’s Handbook of Experimental Immunology (1967).

A

12 5 ml volume of saturated ammonium sulphate solution (SAS),
adjusted to pH 6.5 with concentration ammonium hydroxide,
was added to 350 ml of serum (this gives a 26.35^ saturation
of SAS).

The mixture was allowed to stand 15 minutes and

then centrifuged.

The sediment was washed twice with 100

ml of 40^ SAS, and re suspended in *9fo NaCl, re precipitated
twice with 50$& SAS, and washed as above.

The final sedi

ment was then resuspended in .9^ NaCl, dialysed against
.9^ NaCl, and finally dialysed against distilled water.
The precipitated protein was centrifuged and resuspended in
phosphate-buffered saline pH 7.2 (PBS).

This globulin

solution was divided into two equal portions and one por
tion was treated with 0.6^ 2-mercoptoethanol (2-ME), Sigma,
St..Louis, Missouri.
against PBS.

The 2-ME-treated portion was dialysed

A 5 nil alliquoit was lyophilized and weighed

to determine the amount of globulin.

Animals received

9.4 mg of globulin in 5 ml.
Preparation of Soluble Mediators Derived from Rabbit Lympho
cytes Presensitized with Complete Freund’s Ad.juvant (CFA)
The basic procedure was that of Mooney and Waksman
(1970).

The popliteal and axial lymph nodes were harvested

from animals previously sensitized with CFA.

The lymph
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nodes teased through sterile stainless steel mesh into
#199 media (Grand Island Biological Supply Co., Oakland,
California) with 100 units of penicillin, 100 ug strep
tomycin per ml.

The cells were washed once in 100/Earle*s

(Grand Island Biological Supply Co., Oakland, California)
and centrifuged at 250 x g for 10 minutes.

Cells were

resuspended in #199 and counted in a hemocytometer.

This

cell suspension was then passed through a separatory fun
nel packed with 60 mesh glass beads.

The glass bead column

had previously been incubated at 37^C for ^ hour, covered
with #199 media containing 20^ normal rabbit serum which
had been heated at 56^0 for 30 minutes and centrifuged at
27,000 X g.

After placing the cells on the column, it was

incubated at 37°C for 30 minutes.

The cells and media were

then drawn off the column and the column was washed with
#199 media with 20^ normal rabbit serum until the elute was
no longer cloudy.

The suspension was centrifuged at 250 x g

for 10 minutes to collect the cells.

The cells were counted
and adjusted to a concentration of 1 x 10 7 cell per ml in
#199 media containing 5^ normal rabbit serum, 100 units of
penicillin and 100 ug streptomycin per ml.

The lymphocyte

suspension prepared in this manner was 90$^ pure.

Six ml

quantities of the final cell suspension were placed in 30
ml Falcon Plastic tissue culture bottles (Falcon Plastics,
Los Angeles, California).
at 37^C.

They were incubated for 24 hours

One-half of the bottles contained purified
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protein derivative (PPD) at a concentration of 25 ug per ml
and the other half without PPD#

After the incubation

period the supernatants were pooled and centrifuged at
400 X g for 10 minutes#

The resulting supernatants were

stored at -70^0 until needed#
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Chapter III
RESULTS
Immunity in Adult Rabbits
Passive Transfer of Immunity
The initial studies were performed to determine if
resistance to SRF could be transferred from animals
recovered from fibromatosis to normal animals.

Allison

(1966) and Allison and Friedman (1966) reported that a
cell—mediated immune response is responsible for recovery
and immunity to SRF infections.

Spleen cells, PEC, whole

blood, and serum from immune rabbits were injected i.v. in
to groups of 4 animals each, 72 hours after i.d. inoculation
of 0.2 ml of MEM containing a 10"’^ dilution of virus.
7

Animals in group 1 received 2 x 10' PEC, those in group 2
were given 2 x 10

7

spleen cells, those in group 3 were

injected with 10 ml of whole blood, and those in group 4
received 10 ml of serum.
treated.

Animals in group 5 were not

The surface area of the tumor was determined daily,

The results of this experiment are shown in Figure 1.
Spleen cells and PEC were eliminated from the protocol
of later experiments, as they seemed to offer no protection.
It was also decided to separate whole blood into serum and
peripheral white blood cells.

Four groups of four animals

were used; animals in group 1 received 10 ml of immune
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Figure 1. The surface area of fibromas
produced in rabbits infected by intradermal injection of a 10”^ dilution of
fibroma peritoneal exudate cells, spleen
cells, whole blood or serum from rabbits
recovered from fibromatosis
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7
serum; those in group 2 were given 2 x 10' buffy coat cells,
and those in group 3 were injected with 10 ml of immune
serum plus 2 x 10^ buffy coat cells (i.v*) 72 hours after
infection.

A control group (4) received no treatment.

areas of the tumors were calculated daily (Figure 2).

The
The

results from these two studies indicate that resistance to
the SRFV cannot be transferred with immune spleen cells or
PEC.

Some resistance can be transferred using immune serum

and immune serum plus buffy coat cells.

The second experi

ment was repeated using groups of seven animals each.

The

volumes of the lesions rather than their areas were determined
in this experiment (Figure 3).

No significant resistance

was transferred in this experiment.
Soluble Mediators
In some instances soluble products of.specificallystimulated lymphocytes (soluble mediators) have been shown
to suppress the growth of tumors (Bernstein, ^

al., 1971)•

Soluble mediators were prepared and harvested as previously
described.

The supernatants were tested to determine whe

ther they possessed the ability to induce a reaction simi
lar to delayed cutaneous hypersensitivity.

A .2 ml volume

of supernatant fluid from PEC of rabbits sensitized with
CFA which had been incubated in the presence of PPD was
injected i.d. into two separate sites on the flanks of
each of 2 normal rabbits.

The same amount of supernatant
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fluid from the same sensitized cells incubated without PDD
was injected into 2 other sites on these animals.

Measure

ments of the reactions were taken at 6, 12, 24 and 4Ô hours
(Table 1).

The soluble mediators possessing the ability to

induce a skin reaction were tested for their ability to
suppress the growth of fibromas. Stock fibroma virus was
—Zl
diluted 10
in the soluble mediator. Two—tenths ml of this
mixture was injected i.d. into 5 sites on each side of 4
rabbits.

Two control rabbits were inoculated with an equal

amount of virus without soluble mediator.

Skin reactions

due to SRF were of the same magnitude as those previously
noted.

The tumors in the experimental animals enlarged

and regressed at the same rate as those on the control
animals.

Thus, despite a strong skin reaction induced with

soluble mediator, no protection was provided against tumor
induction by the virus.
Resistance to Reinfection
Allison (1966) inoculated rabbits with fibroma virus
at two i.d. sites and, at daily intervals thereafter, the
animals were injected on a different site with infectious
virus.

Tumors developed at the original site as well as

at sites inoculated with virus on days 2 to 4.

At the site

infected with virus on day 5 a delayed-type response
occurred, but no tumor developed.

A similar procedure was

employed in this investigation to test susceptibility to
reinfection with the virus.

Five rabbits were injected
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i.d. with 0.2 ml of MEM containing a 10”^ dilution of the
stock virus suspension, and all animals developed tumors
which were first palpable on day 4*

On this day and for

5 succeeding days, the animals received a single i.d.
injection of the same amount of virus.

No tumors developed

on any of the animals, with the exception of the tumor
at the original inoculation site.

Contrary to Allison's

results, injection of live virus failed to provoke delayed
responses.

Heat-killed suspensions of 10

—1

—2

and 10

dilutions of the original suspension injected i.d. on day
10 also failed to produce delayed reactions.
BCG Therapy in Normal Animals

Live BCG has been used in several instances to retard
the growth of tumors and leukemias (Zbar, et ^ . , 1971»
Schwartz, et ^ . , 1971; Mat he, ^
1971).

, 1969; Larson, et al. *

In a study devised to determine the effect of

injection of viable BCG into established fibromas, 7 normal
animals were injected i.d. at 6 sites on each flank with
10"^ dilution of the original virus solution.

As soon as

the tumors were palpable (4 days) .2 ml of a BCG suspension
containing approximately 4 x. 10^ organisms was injected into
the base of the tumors present at alternate sites.

During

the first few days the tumors at the sites treated with BCG
continued to grow at the same rate as those at the untreated
sites.

Later measurement of the size of the tumors on the
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Table 1. Volume of skin reactions induced in normal rabbits by intradermal
injection of 0.2 ml of fluid harvested after incubation of peritoneal
exudate cells of rabbits sensitized with CFA with or without PPD.
a

Time of Reading

b
Ave. Vol. of 4 Sites Injected with
Super, from Cells Incubated with PPD

Ave. Vol. of 4 Sites Injected
with Super, from Cells
Incubated w/o PPD

(/)

CO
CD

Q.

6 hours

28.6 mm^

0

12 hours

34*2 mm^

0

24 hours

35*2 mra^

0

48 hours

9,2 mm^

0

Volumes calculated by formula suggested by Waksman, 195^.

=

=
=
=
=

volume of lesion in mm',3
width of lesion in mm
le^th of lesion in mm
thickness of lesion in mm

Two sites on each of two rabbits

2
Q.
C

g
"3O
"G

2
Q.
2

■c

Formula (W x L x JT)0.75 = V
V
W
L
T

"CDO

CD

measured at right angles to one another

O
C

g

c
co
o
CD
Q.

"O
8
"3O
2
Q.
CD

Q1
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treated animals became difficult since the reaction to BCG
produced an added volume to the tumors.

More métastasés

were observed in the treated animals than in the controls,
BCG Therapy in BCG-Immune Animals
A similar study was performed using BCG-immunized
animals.

Five rabbits were given ,2 ml of BCG suspension
7
i.v. containing 2.4 x. 10 viable units per ml. Three weeks
later the animals were skin-tested by i.d. injection of .8

ug of PPD in .2 ml volume, and all gave strongly positive
skin-test reactions.

Three non-immunized animals were

employed as controls.

All of the animals were injected i.d.

at 6 sites on each flank with a 10"”^ dilution of the stock
virus suspension.

When the tumors were palpable (4 days)

they were injected into the base with either 4 x 10

viable

BCG organisms, 8 ug of PPD, or normal sterile saline in
volumes of .2 ml.
the

preparations.

Alternate tumors were treated with one of
Delayed skin reactions occurred at the

site of injection of BCG and PPD in the immunized animals
and reactions to BCG occurred in the non-immuni zed animals.
All tumors, however, enlarged at approximately the same rate
regardless of treatment.
Non-Specific Immunity with BCG
Another study was performed to determine whether BCGimmunized animals possessed non-specific immunity toward
fibroma infection.

Ten animals were injected i.v. with
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.2 ml of a BCG suspension containing 2.4 x 10
per ml.

7

viable units

Three weeks later the animals were skin-tested

with 8 ug PPD in .2 ml saline and all gave strong skin
reactions.

The BCG—immunized animals and 5 normal animals

were injected i.d. with .2 ml of a 10“^ and 10“^ dilution
of heat-inactivated original stock virus suspension in .2
ml.

Five BCG—immune rabbits served as control.

The skin-

test volumes are presented in Table 2.
Immunity in Newborn Animals
Resistance Induced by Passive Transfer of Immune Serum
Tumors induced by fibroma virus in newborn rabbits
have been reported to grow progressively until the host dies
(Duran-Reynals, 1945» Allison, 1966).

The initial investi

gation of this problem was an attempt to transfer immunity
from adult animals which had recovered from a fibroma infec
tion to infected newborn animals.

Adult animals were bled

by cardiac puncture 3 weeks after infection with fibroma
—1

virus, and were skin—tested with 10

—2

and 10

dilutions of

the original suspension of heat-inactivated virus.
tests were negative.

All skin

The sera were pooled and used in all

investigations with immune adult serum.

Experimental ani

mals were given a single i.d. injection of a 10~^ dilution
of the original virus suspension 36 hours after birth.
litters of each were then divided into two groups of
approximately equal numbers.

One group of animals was
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injected i.p. with 5 ml of immune serum 24 and 43 hours
after infection with virus, and the rabbits in the other
group were not treated.

The animals were observed for the

appearance of tumors (Table 3)»

At various intervals after

the first virus injection, the animals were challenged by
i.d. injection of the same amount of virus (Table 4) to
demonstrate the presence or absence of active resistance
to reinfection with SRF.

A total of 10 ml of serum was

found to protect almost all animals from virus infection.
All of the treated animals developed fibromas with a second
virus challenge, while untreated animals did not.
Titration of Immune Serum
An attempt was made to determine the amount of immune
adult serum needed to protect newborn rabbits which had
been previously infected with fibroma virus.

All dilutions

of seinim were given i.p., and equal volumes were given 24
and 43 hours after injection of virus.

Rabbits were given

an i.d. injection of .2 ml of a 10"^ dilution of stock virus
suspension 36 hours after birth.

Five ml of serum was

sufficient to protect animals from developing tumors.

These

animals were observed for the appearance of tumors, and were
re challenged with a single i.d. injection of .2 ml of 10“^
dilution of the original virus suspension at Ô weeks of age
(Table 5).
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Figure 4 - Average tumor volume of
fibromas of normal rabbits compared to
that of rabbits immunized three weeks
prior to virus challenge with .2 ml of
a BCG suspension containing 2.4 x 10?
organisms per ml.
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Table 2. Volumes of skin reactions of BCG- and fibroma-immune, fibroma-immune,
and BCG-immune animals challenged with 10“^ and 10“^ dilutions of
heat-inactivated fibroma virus and 6 ug of PPD.

Animal
BCG- and
Fibroma-Immune

1
2
3
4

5
6
7
8
9
10
Average

Volume of B ug PPD
Skin-Test Lesion

Volume of 10“1 uiXucion volume 01 iu-2 Dilu
tion of Heat-Inacti
of Heat-Inactivated
vated Skin-Test Lesion
Skin-Test Lesion

24.3
77.6

16.2
25.6
19.2
7.2
8.4
75.6
5.0
7.2
32,0
6.4
20.3

9.8
3.6
0.0
1.2
0.0
6.0
5.0
4.0
3.0
3.6
3.6

147.0
30.0
75.6
49.5
159.6
133.9
37.1
99.0

19.8

Fibroma-Immune

1
2
3
4
5
Average

0.0
0.0
0.0
0.0
0.0
0.0

32.0
7.2
0.0
0.0
0.0
7.8

0.0
0.0
0.0
0.0
0.0
0.0

BCG-Immune

1
2
3
4
5
Average

80.0
130.0
49.6
94.3
92.4
89.1

0,0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0

_ _________

Volumes calculated in Table 1.
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Table 3. Number of newborn rabbits (36 hours old) developing
fibromas following i.d. challenge with a 10"^^ dilution of
stock SRFV. Controls not treated with specific immune serum.
Treated animals injected i.p. with specific immune serum^.

(A

(
(/
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CD

Q.

Litter No.
1

Treated Group
No./Group
No./Tumors
3

0

Control Group
No./Tumors
No./Group
1

1
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2
Q.
C
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2

5

0

3

3

3

5

0

3

3

4

5

1

5

5

5

5

0

6

6

= A total of 10 ml of serum was administered to each treated
animal, 5 ml at 24 hours and 5 ml at 48 hours after virus
challenge.
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Table 4. Number of newborn rabbits developing
fibromas on second i.d. challenge with a 10~4
dilution of SRFV. Controls not treated with specific
immune serum. Treated animals injected i.p, with
specific immune serum at 50 and 75 hours of age.

-4-

hitter No.

Age at Second
Virus Challenge

Treated Group
No./Group No,/Tumors

Control Group
No./Group No./Tumors

(
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Q.
C

g
"3G
"O

1

4 weeks

3

2

1

0

2

8 weeks

5

5

3

0

2
Q.
2

3

6 weeks

5

5

3

0

■c

4

5 weeks

5

4

5

0

5

7 weeks

5

5

6

0

All control animals developed tumors following primary challenge with same
dilution of virus.
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Table 5. Effect of varying the amount of specific immune serum
given by i.p. injection to newborn animals on the number of animals
which develop fibromas.

C
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CD

Q.

Total Serum Adminis.

5 ml.

No. In Group

4

No. of Tumors

1

No. of Tumors When
Challenged at 8 Wks.

"CDO

3

2
Q.
C
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2.5 ml.

4

4

0

1.25 ml.

4

4

0

2
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2
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4

0
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Serum administered in 2 i.p. injections,
the total amount of serumgiven at
24 hours and the second half at 48 hours after virus challenge.
Animals were infected with a .2 ml injection of a 10'
virus suspension at 36 hours of age.
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Serum Fractionation
Fourteen 36-hour old rabbits were given i.d. .2 ml
of a 10"^ dilution of the stock virus suspension.

Five of

these rabbits received 9.4 mg of the 2-ME treated globulin
preparation, five were given 9.4 mg of the untreated pre
paration, and four were not treated.
observed for tumor development.

The animals were

None of the treated ani

mals developed tumors.
Resistance Induced by Transfer of Normal Adult Macrophages
A group of seven rabbits, 36-hours old, was selected.
Each animal was injected i.d. with .2 ml of a 10~^ dilution
of the original virus suspension.
4 animals were given i.p. 6.1 x 10
in 1 ml.

Twenty-four hours later
n

normal adult macrophages

All of these animals and the 3 control animals

developed tumors in 5 days.

The tumors on animals treated

with macrophage were larger and metastasis were more preva
lent.

All of the tumors in both groups regressed at the

same rate and eventually disappeared.

None of the animals

developed tumors when injected i.d. with 0.2 ml of a 10 ^
dilution of the original virus suspension administered when
the animals were 5 weeks of age.
Heat-Inactivated Serum
Immune adult rabbit serum was heated at 56^0 for 2
hours.

Two 5 ml i.p. injections were given to 4 animals

which had received an injection of a 10”^ dilution of the
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original virus suspension.

One sérum injection was given

24 hours and the other 48 hours after virus injection.

Only

one of the four treated animals developed a tumor in 5 days,
while all five of the control animals developed tumors in
5 days.
Death Rate in Newborn Rabbits Infected with SRF
Contrary to results obtained by Duran-Reynals (1945)
and Allison (1966) no fatalities attributed to the SRFV
occurred among the young rabbits used in these studies.
Some tumors in newborn animals eventually attained a size
approximating 1/3 to 1/2 that of the animal, but all of these
eventually regressed.

None of the animals recovered from

fibromatosis could be reinfected at a later date.
Virus Neutralization Test
A group of nine rabbits was given a single i.d. dose of
virus 36 hours after birth, and three of these were treated
with 10 ml of specific immune serum.
these animals.

No tumors developed in

The remaining six animals, which were not

treated, developed tumors.

Eight weeks later serum was

obtained from all nine rabbits and a virus neutralization
test was performed.

There were no neutralizing antibodies

in the serum of treated animals ; however, the serums of the
infected control rabbits contained antibodies with titers
ranging from 1:2 to 1:8 (Table 6).

When challenged with a

single .2 ml injection of a lO”^ dilution of virus, 24 hours
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Table 6. Correlation of virus neutralizing titers against SRFV to
the number of fibromas developed on challenge with an i.p. injection
of a 10~^ dilution of the original virus suspension.
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Normal rabbit serum possessed no virus-neutralizing titer. Virus incubated with
saline was fully active in tumor induction.
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after the serum sample was observed, treated animals deve
loped tumors but untreated rabbits did not*

A control of

normal rabbit serum had no virus—neutralizing capacity, and
a second control of virus incubated in saline was fully
active in tumor induction.

The immune serum pool had a

titer of 1:4.
Treatment with ALS

Seven 36-hour old rabbits were injected i.d. with .2
—A
ml of a 10 ^ dilution of the original virus suspension.
Four animals were treated with three 1 ml injections of ALS
i.p. at 4Ô hour intervals.
as controls.

Three untreated animals served

The animals were observed for tumor develop

ment and growth.

The ALS-treated animals developed tumors

sooner and the tumors on these animals grew larger than
those on untreated animals.
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Chapter IV
DISCUSSION
Immunity in Adult Rabbits
Passive Transfer of Immunity
Data presented in Figures 1 and 2 indicate that intra
venous injection of serum, whole blood, and peripheral white
blood cells plus serum from animals recovered from fibroma
infections influences the course of infections with fibroma
virus in adult rabbits.

In these experiments, injection of

the above substances was withheld until 72 hours after the
animals were infected in order to allow the virus to become
firmly established prior to institution of therapy.

Immune

serum does contain virus-neutralizing antibodies but these
may be ineffective from a therapeutic standpoint.

The

criterion for protection was reduction of the average area
of tumors in the treated animals as compared to that in
control rabbits.

Spleen cells, peritoneal exudate cells and

peripheral white blood cells which were washed to decrease
the effect of serum, did not influence the effects of
infection.
Evidence obtained by Allison (1966) and Allison and
Friedman (1966) indicated that recovery from and immunity to
SRF is dependent upon cell-mediated immune responses.

If

only cell—mediated responses are responsible for immunity as
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Allison and Friedman postulate, passive transfer of
resistance should be accomplished by transfer of sensi
tized lymphocytes or macrophages, but not by transfer of
serum.

Our findings show that passive transfer of cells

from immune animals to animals infected 72 hours previously
does not confer resistance to infection; however, humoral
antibodies do confer some degree of immunity.

It appears

(Figures 1 and 2) that specific immune serum plus peri
pheral white blood cells gives the greatest amount of pro
tection to infected recipient animals.

A plausible expla

nation for this observation is a synergistic action of
antibodies and cells.

The serum could contain opsonizing

antibodies which prepare virus particles or induced tumor
cells for phagocytosis and subsequent destruction by macro
phages in the buffy coat cells.

It is possible that greater

protection might be afforded if immune serum or immune serum
and buffy coat cells were administered soon after infection
with virus rather than after 72 hours.
will be discussed later.

Evidence for this

The results in Figure 3, using

decreased tumor volume as a criterion, indicate that no
significant protection of adult animals was obtained when
they were treated with specific immune serum, immune buffy
coat cells, or cells with immune serum 72 hours after virus
infection.

Further study in this area is indicated,

expecially an investigation of the relationship of time of
treatment to the amount of protection given by specific
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immune serum.
The above results show that neither spleen cells,
PEC, nor circulating cells from rabbits recovered from
fibromatosis are capable of conferring resistance to SRFV
in adult rabbits infected 72 hours previously with this
agent.

The influence of immune serum also seems debatable.

However, since it is stated that cell—mediated responses
are important in the recovery of animals from virus infec
tions, other studies were done to determine if non-specific
resistance could be established and if ^

vitro correlates

of cell-mediated immunity could be demonstrated.
Soluble Mediators
Skin reactive factor (SM-SRF) is one of the soluble
mediators produced when sensitized lymphocytes are exposed
to specific antigen in vitro (Mooney and Waksman, 1970).
Following injection into normal animals, SRF produces a
lesion which may be considered as a compressed delayed
reaction.

Specific antigen given i.d. into sensitized

guinea pigs produces a reaction which appears in 6 to 10
hours, reaches a peak in 24 to 46 hours, and gradually
decreases in size.

The same antigen injected i.d. into a

normal guinea pig will not produce a reaction unless the
agent is a toxic one.

On the other hand, SM-SRF injected

into a normal animal produces a reaction which develops in
2 to 4 hours, reaches a peak in 6 to 12 hours, and then
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gradually disappears.

The skin reaction is fore-shortened

because the production of the active material has been
accomplished

vitro rather than ija vivo,

^

Heise,

al.

(i960) have shown that production of SRF is not demonstrable
in tissue culture until 9 hours after sensitized lymphocytes
and specific antigen are mixed and incubated at 37°C,
SM-SRF produced in this laboratory by incubation of PEC from
rabbits sensitized to CFA together with PPD causes a skin
reaction when injected i.d, into normal rabbits.

The lesion,

however, is well-developed in 6 hours, reaches a peak in 12
to 24 hours, and disappears by 46 hours.

Active delayed

reactions in sensitized rabbits induced by injection of
specific antigen reach their maximum size in 24 to 40 hours
and persist for several days.
Bernstein, ^

,

In experiments performed by

(1971) the soluble products of speci

fically-stimulated lymphocytes (soluble mediators) were
mixed with ascites cells from the sixth generation of a
transplantable hepatoma and injected i.d, into the skin of
normal guinea pigs.

Tumor growth was suppressed in guinea

pigs inoculated with this mixture.
preparation used by Bernstein, et

The soluble mediator
possessed the ability

to produce a reaction similar in appearance to delayed
cutaneous hypersensitivity, as did the preparation used in
this study.

The SM—SRF reaction, when examined histolo

gically, shows an accumulation of mononuclear cells (Bernstein,
et al, 1971)*

When rabbits were injected with SRF suspended
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in soluble mediator prepared from lymphocytes of rabbits
specifically-stimulated with CFA, no inhibition of tumor
growth was observed*

It must be assumed that mononuclear

cells which accumulate at the reaction sites are incapable
of phagocytosing and destroying the virus particles.

This

is again evidence against the participation of cell-mediated
immunity in immunity against SRF,
Resistance to Reinfection

In the original study by Allison (1966) it was found
that adult rabbits are immune to reinfection with SRFV
days after primary infection.

Our experiments confirm the

observation that immunity to reinfection is developed by 5
days after infection.

Contrary to Allison’s results, how

ever, no cutaneous delayed hypersensitivity response could
be elicited in infected animals by i.d. injection of either
live or heat-inactivated virus.
BCG Therapy in Normal Animals

In some instances, (Zbar, ^

al•» 1971) viable BCG

injected directly into tumors of normal animals will cause
the tumor to regress.

In the SRF system, however, increased

rate of tumor regression in treated animals was not observed.
Viable BCG injected into the base of the tumor causes an
active infection at that site.

It appears that the lymphoid

cells which aggregate at the site of injection of BCG are
ineffective against SRF even though a typical tubercle (a
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manifestation of delayed hypersensitivity) is formed at
the site.
BCG Therapy in BCG-Immune Animals
Although strongly positive skin reactions develop when
viable BCG or Ô ug of PPD is injected into the base of
fibromas present on rabbits previously immunized with BCG,
no evidence of protection is observed.

From this data, it

would appear that the macrophages which assemble in the
delayed reaction are

incapable of phagocytosing and destroy

ing either the virus

particles or the fibroma cells.

Non-Specific Immunity with BCG
The results presented in Figure 4 indicate that BCGimmune animals do not possess non-specific immunity toward
SRF.

Tumors induced in BCG—immune animals appear, enlarge,

and regress at the same rate as those in normal animals.
Thus, while BCG-induced non-specific immunity does enhance
immunity to certain tumors and
(Zbar, et al., 1971»

leukemias in man and animals

Schwartz, et al., 1971» Mat he, et al.,

1971; Larson, £t al., 1971), it does not appear to be
effective in the SRF system.

An interesting observation

was made when animals in this experiment were skin-tested
with PPD and a suspension of heat-inactivated virus.

The

results in Table 2 indicate that BCG has an adjuvant effect
with respect to the induction of specific delayed
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hypersensitivity in rabbits subsequently infected with SRF.
Although BCG immunization gave no protection, it did
increase the volume of skin-test lesions in animals immune
to both BCG and SRF.

These findings indicate that a delayed

skin response to SRF cannot be correlated with immunity to
the virus.

Delayed hypersensitivity reactions in animals

immunized with BCG are much larger than those in animals
immunized with SRF, while tumor size, growth, and regression
are essentially identical in the two groups.

The positive

skin—test reactions against SRF observed in animals immu
nized with BCG and SRF were the only ones obtained in these
studies, although SRF-iramune animals were skin-tested in an
identical manner.

It is apparent from discussion presented

thus far that no supporting evidence for the participation
of delayed hypersensitivity in immunity to SRF was obtained
in this study.
Immunity in Newborn Rabbits
Resistance Induced by Passive Transfer of Immune Serum
New born rabbits have been shown to be extremely
sensitive to tumor induction by SRFV (Duran-Reynals, 1940,
1945; Allison, 1966; Allison and Friedman, 1966).

For this

reason passive transfer of resistance by either cells or
serum would require that the factor be quite effective.
Since the results previously discussed show that lymphoid
cells of animals recovered from fibromatosis are not
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effective In transferring resistance to normal rabbits,
the following studies were undertaken to determine if trans
fer of immune serum could confer resistance to newborn ani
mals.

The results indicate that i.p. injection of 10 ml

of specific immune serum into newborn rabbits infected with
fibroma virus 24 hours prior to treatment results in almost
complete suppression of tumor growth (Table 3)*

All of the

untreated rabbits develop tumors one week after virus
challenge.

Thus, administration of immune serum to newborn

rabbits protects them against infection with SRFV.

This

protection cannot be attributed to neutralization of the
initial inoculum of virus by serum, since the animals were
infected 24 hours before treatment.

It is interesting to

observe that following challenge with a second injection of
virus, all of the animals which developed tumors on initial
challenge were resistant to reinfection.

All animals treated

with serum which did not develop tumors on primary challenge
did so following the second challenge with virus.

The lone

animal treated with serum which developed a fibroma follow
ing primary challenge with virus was immune to the secondary
challenge.

These findings indicate that treatment with spe

cific immune serum resulting in prevention of tumor—formation
interferes with the animal’s ability to develop active
immunity to the virus or the tumor cells.

The only reason

which seems to explain this situation is that immune serum
prevents the spread of virus from cell to cell and, as a
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consequence, the amount of viral antigen released is
insufficient to stimulate the immune system to produce the
factors necessary for active immunity.

This situation is

remindful of that occurring during the treatment of measles
with immune serum.

Treatment of exposed children too soon

after their exposure to a case of measles will prevent
infection, but will not result in the production of active
immunity.

It is evident that passive immunity may be

achieved by transfer of specific immune serum to newborn
rabbits.

The minimal amount of specific immune serum effec

tive in preventing tumor formation by newborn rabbits is
5 ml of the serum pool used in these studies.

This repre

sents a large fraction of the total serum pool of these
animals.

Studies performed using r globulin preparations

indicate that the protecting antibodies are in the

^O

immunoglobulin.
Heat-Inactivated Serum
Ten ml of serum heated at $6^0 for 2 hours given in
two i.p. injections to a newborn rabbit infected 24 hours
previously with SRFV was still active in the preparation of
tumor development.

Based upon this evidence, it can be

assumed that the active portion of the serum is non-heat
labile.
Two in vitro studies support the idea that humoral
antibodies are involved in regression of SRF-induced tumors.
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Tompkins, et aT., (1970) have shown that sera from rabbits
with regressed fibromas will react in a specific manner
with the surface of viable fibroma—infected cells.

This

evidence implies that animals infected with fibroma virus
produce antibody with the capacity to bind with the surface
of infected cells, but gives no indication as to the
sequelae of this primary interaction.

Singh, et al.,

(1972) presented evidence that animals bearing SRF-induced
tumors produce antibodies cytotoxic to tissue culture cells
infected with the virus.

This study also showed that 19S

antibodies appeared on the 7th day of infection and reached
peak titer on day 13» and disappeared by day 17.

On the

other hand, 7S antibody was barely detectable on day 7»
reached maximum titer on day 13 » and remained high for at
least $0 days.
Resistance Induced by Transfer of Normal Adult Macrophages
The findings of Zisman, ^

aA. (1970) and of Duran-

Reynals (1940, 1945), Allison (1966), and Allison and
Friedman (1966) demonstrated that young animals are more
susceptible to infection with certain viruses than are older
animals.

It was shown by Zisman, et

(1970) that admin

istration of macrophages from older mice increased the
resistance of suckling mice to infection with herpes virus.
The other workers (Duran-Reynals 1940, 1943; Allison 1966;
Allison and Friedman 1966) showed that young rabbits infected
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with SRFV developed larger tumors than did adult animals*
Our studies however, fail to show that administration of
macrophages of normal adult rabbits to newborn rabbits
induces resistance to infection with SRFV*

Rather, it

appears that newborn rabbits treated with macrophages of
normal adult rabbits develop a greater number of metas
tatic lesions than do normal suckling rabbits.

The

metastatic lesions in the treated animal may occur when
macrophages engulf virus particles which they are unable
to destroy.

The virus is then disseminated by the macro

phages and freed by their death.

A metastatic lesion may

then develop if the virus is not pahgocytosed and destroyed
by another macrophage.

This observation would seem to

indicate that the animals possess no active immunity to the
SRF at this age.

If such immunity were present and anti

bodies active against the virus were produced the observed
métastasés would not occur.

Further study is indicated in

this area using specific immune macrophages and normal
macrophages given with an amount of specific immune serum
insufficient in itself to protect the animal from fibroma
infection.
Virus Neutralization Test
Data in Table 5 indicates that the virus neutralization
titer of a rabbit's serum can be correlated to the animal's
resistance to reinfection with the SRF.

Animals treated
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with specific immune serum which prevented tumor induction
on primary challenge developed no virus neutralizing titer
and were susceptible to tumor induction when rechallenged
at a later date*

This evidence supports the concept that

true passive immunity is transferred with specific immune
serum.
Treatment with ALS
Animals treated with ALS 24 hours after virus infection
develop tumors sooner than non-treated control animals.

The

tumors in the treated animals also grow to a larger size
than those in the controls.

This is to be expected as ALS

depresses the animal’s immune system, allowing the tumors
to grow to a much larger size.
There are basically two types of specific immunity,
humoral and cell-mediated.

The former is characterized by

specific antibodies and the latter by specificallystimulated lymphocytes.

Humoral immunity may be transferred

from one animal to another with serum, cell-mediated immu
nity may be transferred with lymphoid cells.

Both types of

immunity may be involved in recovery from viral infections.
It appears that in measles infection antibody plays the more
important role, while in herpes simplex infection it is cellmediated immunity (Allison, 1966) which is more important.
These are only two examples of many virus infections in
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which one type of immunity or the other appears to play
the major role.
In our studies with adult rabbits infected with the
SRFV, it was shown that resistance to the infection could
not be transferred with lymphoid cells from immune animals*
BCG, which enhances the cell-mediated response, was also
ineffective in enhancing resistance to SRFV in both normal
and BCG—immune animals.

These results indicate that cell-

mediated immunity plays little if any role in resistance
to SRFV.

Animals immunized with both BCG and SRFV did,

however, display a positive delayed cutaneous hypersensi
tivity reaction when injected i.d. with heat-inactivated
virus.

SRFV-immune animals did not give positive skin

reactions when injected in the same manner.

This indicates

that a positive delayed cutaneous hypersensitivity reaction
cannot be correlated to cell-mediated immunity against the
SRF.

Attempts to transfer resistance to the SRF with immune

serum were not successful in all cases.

A possibility exists

that immune serum would be more effective if administered
sooner after virus infection, i.e. 24 hours.
In newborn animals it was observed that immune serum
given 24 hours after virus infection will passively transfer
resistance in virtually all of the treated animals.

These

animals, however, did not develop active resistance to the
virus and developed tumors when challenged a second time
with the virus.

All control animals which received no
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treatment developed tumors on primary virus challenge, but
were immune to a second challenge of virus #

The activity

against SRFV appears to be the IgG portion of the serum.
In vitro support for this concept is found in work by
Singh,

(1972).

ALS, which depresses the immune

response, lessens an animal’s ability to resist fibroma
infection.

Since ALS inhibits cell—mediated immunity more

than humoral immunity, it appears that cell-mediated immun
ity may also play a role in SRFV resistance.

Normal adult

macrophages do not inhibit SRFV infection when given to
infected newborn rabbits.

This again indicates that cell-

mediated immunity is less important than humoral antibody
in resistance to the SRFV infections.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

54
Chapter V
SUMMARY
The Shope rabbit fibroma virus (SRFV) induces a local,
benign tumor which spontaneously regresses in adult rabbits.
The virus in some instances induces a fatal generalized
disease in newborn rabbits.

Previous work by Allison (1966)

and Allison and Friedman (1966) attributes resistance to
SRFV to a cell-mediated immune response.
Attempts were made passively to transfer immunity from
SRFV-immune animals to adult domestic rabbits infected 72
hours previously with the virus.

Immune peritoneal exudate

cells, immune spleen cells, and immune peripheral white
blood cells were ineffective in transferring resistance.
Immune serum, immune whole blood and immune serum mixed
with immune peripheral white blood cells were effective to
a small degree.
Attempts to produce non-specific immunity with BCG
and soluble mediator-skin reaction factor were unsuccessful.
Delayed hypersensitivity reactions to heat-inactivated virus
suspensions appeared only in animals which were immune to
both BCG and SRFV.
Passive transfer of resistance by immune serum was
accomplished in newborn rabbits infected with virus at 36
hours of age.

Five ml of immune serum was sufficient to

protect the animals.

The active factor in the serum is
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non-heat labile and appears to be 7S or IgG immunoglobulin.
Animals treated with immune serum after virus challenge at

36 hours developed no tumors, however, when challenged
again with virus these animals developed tumors.

Animals

not treated with serum all developed tumors on initial virus
challenge, but were immune to a second virus challenge.
Treated animals developed no virus neutralizing titers after
initial virus challenge, while untreated animals did.
Newborn animals treated with normal adult macrophages
after virus infection developed tumors with more tendency
to metastasis than untreated controls.
Treatment with anti—lymphocyte serum caused tumors to
appear earlier and grow larger in newborn animals.
From these results we postulate that resistance to
SRFV is not completely dependent upon a cell-mediated immune
response, but rather humoral antibodies.
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